This research aimed to evaluate the efficacy of KF supplementation to modulate two key and intertwined molecular processes underlying both AD and T2DM, i.e., the disruption of brain insulin signalling and the establishment of a chronic inflammatory state. The gene discussed is INS; the disease is type 2 diabetes mellitus.